NAYA Biosciences (NAYA) Competitors $2.39 +0.78 (+48.45%) As of 04/30/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock NAYA vs. LUCY, AMIX, TIVC, NAOV, NUWE, GCTK, QNRX, CHEK, VERO, and HSCSShould you be buying NAYA Biosciences stock or one of its competitors? The main competitors of NAYA Biosciences include Innovative Eyewear (LUCY), Autonomix Medical (AMIX), Tivic Health Systems (TIVC), NanoVibronix (NAOV), Nuwellis (NUWE), GlucoTrack (GCTK), Quoin Pharmaceuticals (QNRX), Check-Cap (CHEK), Venus Concept (VERO), and Heart Test Laboratories (HSCS). These companies are all part of the "medical equipment" industry. NAYA Biosciences vs. Innovative Eyewear Autonomix Medical Tivic Health Systems NanoVibronix Nuwellis GlucoTrack Quoin Pharmaceuticals Check-Cap Venus Concept Heart Test Laboratories NAYA Biosciences (NASDAQ:NAYA) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk, valuation, community ranking and media sentiment. Is NAYA or LUCY more profitable? NAYA Biosciences has a net margin of -119.91% compared to Innovative Eyewear's net margin of -514.01%. NAYA Biosciences' return on equity of 0.00% beat Innovative Eyewear's return on equity.Company Net Margins Return on Equity Return on Assets NAYA Biosciences-119.91% N/A -41.72% Innovative Eyewear -514.01%-115.86%-105.40% Does the MarketBeat Community prefer NAYA or LUCY? Innovative Eyewear received 1 more outperform votes than NAYA Biosciences when rated by MarketBeat users. CompanyUnderperformOutperformNAYA BiosciencesOutperform Votes1100.00% Underperform VotesNo VotesInnovative EyewearOutperform Votes2100.00% Underperform VotesNo Votes Which has higher valuation and earnings, NAYA or LUCY? Innovative Eyewear has lower revenue, but higher earnings than NAYA Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNAYA Biosciences$6.23M0.17-$8.03MN/AN/AInnovative Eyewear$1.64M2.91-$6.66M-$6.27-0.31 Do insiders & institutionals have more ownership in NAYA or LUCY? 12.0% of NAYA Biosciences shares are owned by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are owned by institutional investors. 1.8% of NAYA Biosciences shares are owned by insiders. Comparatively, 6.4% of Innovative Eyewear shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Do analysts rate NAYA or LUCY? NAYA Biosciences currently has a consensus price target of $24.00, suggesting a potential upside of 1,390.68%. Given NAYA Biosciences' stronger consensus rating and higher probable upside, equities analysts clearly believe NAYA Biosciences is more favorable than Innovative Eyewear.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NAYA Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Innovative Eyewear 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor NAYA or LUCY? In the previous week, NAYA Biosciences had 2 more articles in the media than Innovative Eyewear. MarketBeat recorded 5 mentions for NAYA Biosciences and 3 mentions for Innovative Eyewear. Innovative Eyewear's average media sentiment score of 0.48 beat NAYA Biosciences' score of 0.31 indicating that Innovative Eyewear is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NAYA Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Innovative Eyewear 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, NAYA or LUCY? NAYA Biosciences has a beta of 2.03, indicating that its stock price is 103% more volatile than the S&P 500. Comparatively, Innovative Eyewear has a beta of 3.03, indicating that its stock price is 203% more volatile than the S&P 500. SummaryNAYA Biosciences beats Innovative Eyewear on 9 of the 15 factors compared between the two stocks. Get NAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NAYA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAYA vs. The Competition Export to ExcelMetricNAYA BiosciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.07M$4.37B$5.53B$7.99BDividend YieldN/A39.94%5.11%4.23%P/E RatioN/A30.8122.6518.64Price / Sales0.1755.50401.98103.80Price / CashN/A51.0838.1834.62Price / Book-0.786.096.754.30Net Income-$8.03M$68.71M$3.22B$248.44M7 Day Performance-20.69%-0.18%1.66%1.81%1 Month Performance-19.10%-2.33%4.17%4.40%1 Year PerformanceN/A23.51%16.17%5.97% NAYA Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAYANAYA BiosciencesN/A$2.39+48.4%$24.00+904.2%N/A$1.59M$6.23M0.0010Gap UpHigh Trading VolumeLUCYInnovative Eyewear0.3452 of 5 stars$1.98+5.6%N/A-51.6%$4.86M$1.64M-0.209AMIXAutonomix Medical3.4255 of 5 stars$1.97-3.0%$28.00+1,321.3%-96.4%$4.85MN/A-0.151Analyst ForecastNews CoverageTIVCTivic Health Systems0.1807 of 5 stars$7.35+6.4%N/A-75.3%$4.49M$780,000.000.0010Short Interest ↑NAOVNanoVibronix0.2544 of 5 stars$5.81-4.2%N/A-65.0%$4.41M$2.56M-4.7220Short Interest ↑Gap UpNUWENuwellis3.0506 of 5 stars$0.94+7.3%$17.00+1,718.2%-81.7%$4.09M$8.74M-0.0170Upcoming EarningsShort Interest ↓GCTKGlucoTrack1.8637 of 5 stars$0.16+6.7%N/A-99.7%$4.07MN/A0.005Short Interest ↓Gap DownQNRXQuoin Pharmaceuticals0.636 of 5 stars$6.74+2.7%N/A-72.7%$3.97MN/A-1.664Upcoming EarningsShort Interest ↑News CoverageGap DownCHEKCheck-Cap1.2316 of 5 stars$0.66+1.4%N/A-65.4%$3.86MN/A-0.2280Short Interest ↓News CoverageVEROVenus Concept0.9021 of 5 stars$2.69-2.2%N/A-66.5%$3.84M$64.83M-0.34410Gap DownHSCSHeart Test Laboratories2.2559 of 5 stars$3.36+0.6%$13.00+286.9%-62.0%$3.63M$14,700.00-0.4210Short Interest ↑News Coverage Related Companies and Tools Related Companies LUCY Alternatives AMIX Alternatives TIVC Alternatives NAOV Alternatives NUWE Alternatives GCTK Alternatives QNRX Alternatives CHEK Alternatives VERO Alternatives HSCS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAYA) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored"I'm risking my reputation on this"I've stayed quiet for too long, but after everything I've uncovered about what's brewing in the 2025 crypto ma...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.